Advertisement

Topics

Santhera Pharmaceuticals Holding Ltd Company Profile

16:07 EDT 21st June 2018 | BioPortfolio

Santhera Pharmaceuticals is a Swiss biopharmaceutical company focusing on the discovery, development and marketing of small molecule pharmaceutical products for the treatment of neuromuscular diseases. Santhera’s vision is to become the leading specialty pharmaceuticals company offering therapies for a number of indications in this area of high unmet medical need which includes many orphan indications with no current therapy. Santhera has a proven track-record in discovering and developing drug candidates that address severe neuromuscular disorders in orphan or even ultra-orphan diseases. Santhera’s drug pipeline comprises a Phase III program in Friedreich's Ataxia, a Phase II program in Duchenne Muscular Dystrophy and three preclinical programs in diabetes, cachexia/anorexia, and Duchenne Muscular Dystrophy.

Location

Hammerstrasse 47
Liestal
CH-4410
Switzerland

Contact

Phone: 41 (0) 61 906 89 50
Fax: 41 (0) 61 906 89 51
Email: office@santhera.com


News Articles [888 Associated News Articles listed on BioPortfolio]

Santhera Pharmaceuticals Holding AG: Santhera Submits NDA in South Korea for Raxone for the Treatment of LHON

Santhera Pharmaceuticals Holding AG / Santhera Submits NDA in South Korea for Raxone for the Treatment of LHON . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely respon...

Santhera Pharmaceuticals Holding AG: Santhera reicht Zulassungsantrag für Raxone zur Behandlung von LHON in Südkorea ein

Santhera Pharmaceuticals Holding AG / Santhera reicht Zulassungsantrag für Raxone zur Behandlung von LHON in Südkorea ein . Verarbeitet und übermittelt durch Nasdaq Corporate Solutions. Für den In...

Santhera Pharmaceuticals Holding AG: Santhera erhält weltweite Exklusivlizenz von Polyphor zur Entwicklung und Vermarktung eines klinischen Prüfmedikaments für Mukoviszidose und andere pulmonale Erkrankungen

Santhera Pharmaceuticals Holding AG / Santhera erhält weltweite Exklusivlizenz von Polyphor zur Entwicklung und Vermarktung eines klinischen Prüfmedikaments für Mukoviszidose und andere pulmonale E...

Santhera Pharmaceuticals Holding AG: Santhera Obtains Worldwide Exclusive License from Polyphor to Develop and Commercialize Clinical Stage Candidate for Cystic Fibrosis and Other Pulmonary Diseases

Santhera Pharmaceuticals Holding AG / Santhera Obtains Worldwide Exclusive License from Polyphor to Develop and Commercialize Clinical Stage Candidate for Cystic Fibrosis and Other Pulmonary Diseas...

Santhera Pharmaceuticals Holding AG: Santhera Anticipates Receiving a Negative CHMP Opinion on Appeal for Marketing Authorization Application for Raxone in Duchenne Muscular Dystrophy

Santhera Pharmaceuticals Holding AG / Santhera Anticipates Receiving a Negative CHMP Opinion on Appeal for Marketing Authorization Application for Raxone in Duchenne Muscular Dystrophy . Processed ...

Santhera Completes Capital Increase to Settle Obtained License from Polyphor

Santhera Pharmaceuticals Holding AG / Santhera Completes Capital Increase to Settle Obtained License from Polyphor . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely respo...

EMA likely to reject Santhera's label expansion bid for Raxone

Orphan mitochondrial and neuromuscular disease specialist Santhera Pharmaceuticals suffered a 30% drop…

Santhera Anticipates Receiving a Negative CHMP Opinion on Appeal for Marketing Authorization Application for Raxone® in Duchenne Muscular Dystrophy

Santhera Pharmaceuticals Holding AG / Santhera Anticipates Receiving a Negative CHMP Opinion on Appeal for Marketing Authorization Application for Raxone® in Duchenne Muscular Dystrophy . Processed...

PubMed Articles [211 Associated PubMed Articles listed on BioPortfolio]

Letter--Incorporating Real-World Evidence and Patient Value Criteria into Value-Based Frameworks for Relapsed/Refractory Multiple Myeloma.

Orlowski has received research funding from Amgen, BioTheryX, Bristol-Myers Squibb, Celgene Corporation, and Takeda Pharmaceuticals; honoraria from Amgen, Bristol-Myers Squibb, Celgene Corporation, Ja...

Holding immature bovine oocytes in a commercial embryo holding medium: High developmental competence for up to 10 h at room temperature.

Bovine in vitro embryo production (IVP) following Ovum Pick Up (OPU) is all too often hampered by a large time gap between the harvest of oocytes of the first and last OPU session of the day. Immedia...

Genetics of familial hypercholesterolemia: a tool for development of novel lipid lowering pharmaceuticals?

Familial hypercholesterolemia is characterized by high LDL cholesterol and an elevated risk to develop coronary heart disease. Mutations in LDL receptor-mediated cholesterol uptake are the main cause ...

Post-production handling and administration of protein pharmaceuticals and potential instability issues.

The safety and efficacy of protein pharmaceuticals depend not only on biological activity, but also on purity levels. Impurities may be process related due to limitations in manufacturing, or product ...

Disclosure and holding back: Communication, psychological adjustment, and marital satisfaction among couples coping with osteoarthritis.

This study examined two types of illness-related communication (disclosure and holding back) and their associations with psychological adjustment and marital satisfaction in patients with knee osteoar...

Clinical Trials [293 Associated Clinical Trials listed on BioPortfolio]

Energy Cost for Holding a MedGem® Indirect Calorimeter

The goal of this clinical protocol is to perform a randomized crossover study to determine the energy cost of holding the MedGem® device above a person's normal resting metabolic rate (RM...

Kangaroo Holding Effects on Breast Milk

Kangaroo holding is a skin-to-skin method of holding a baby. Many research studies have investigated the maternal and infant benefits associated with kangaroo holding. The purpose of thi...

Kangaroo Holding and Maternal Stress

The primary objective is to determine if kangaroo holding in the first week after birth influences the stress levels of mothers who have delivered their infants prematurely and who require...

Holding, Stress and Bonding During Therapeutic Hypothermia Dyads During Therapeutic Hypothermia

Ten infants undergoing therapeutic hypothermia for hypoxic-ischemic encephalopathy will be enrolled in a new protocol that will allow mothers to hold their infants during the hypothermia t...

The Holding Area LINQ (Reveal LINQ Insertable Cardiac Monitor) Trial is a Prospective, Non-randomized, Single Center Post-market Clinical Trial

The Holding Area LINQ Trial is a clinical trial designed to compare the benefits in conducting impant procedures in the holding area of a hospital operating room vs cardiac catheterization...

Companies [1577 Associated Companies listed on BioPortfolio]

Santhera Pharmaceuticals Holding Ltd

Santhera Pharmaceuticals is a Swiss biopharmaceutical company focusing on the discovery, development and marketing of small molecule pharmaceutical products for the treatment of neuromuscular diseases...

Aeroflex Holding Corp.

Aeroflex Holding Corp. is the holding company for Aeroflex Incorporated, a leading global provider of microelectronic components and test and measurement equipment used by compani...

Alantos Pharmaceuticals Holding, Inc.

Alantos Pharmaceuticals is a dynamic international biopharmaceutical company focused on developing small molecule pharmaceuticals for Arthritic and Metabolic diseases. Headquartered in Cambridge, MA, ...

IMIX Holding AB

IMIX Holding AB, based in Stockholm, is a newly created holding company for the IMIX group. The group is active within the field of digital radiology and consists of sales offices...

VKR Holding A/S

VKR Holding owns companies within five Business Areas, which form the VKR Group: Roof windows and skylights, vertical windows, decoration and sunscreening, thermal solar energy and Natural Ventilation...

More Information about "Santhera Pharmaceuticals Holding Ltd" on BioPortfolio

We have published hundreds of Santhera Pharmaceuticals Holding Ltd news stories on BioPortfolio along with dozens of Santhera Pharmaceuticals Holding Ltd Clinical Trials and PubMed Articles about Santhera Pharmaceuticals Holding Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Santhera Pharmaceuticals Holding Ltd Companies in our database. You can also find out about relevant Santhera Pharmaceuticals Holding Ltd Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record